MetLife: Buyers Defend the 20 EMAMetLife, Inc.BATS:METfinvestnomicsMET is seeing strong buying interest after retracing to the 20 EMA, a level that has repeatedly attracted buyers during the stock’s uptrend. The recent bounce reinforces the bullish setup, with the stock trading above both the 20 and 50 EMAs. MetLife, Inc. is a $63bn market cap company that provides insurance and financial services to individual and institutional customers. It operates through Group Benefits, Retirement and Income Solutions (RIS), Asia, MetLife Holdings, and Corporate and Other. Its offerings include life insurance, retirement and income solutions, pension risk transfers, structured settlements, accident and health products, and other benefit funding and insurance solutions. MET is a wide-moat company that has grown revenue in each of the last three quarters and EPS in two of the last three quarters, with the most recent growth rates of 11% and 5%, respectively. Operating and net margins are 7% and 4%, while ROE and ROIC stand at 12% and 7%. The company has a current ratio of 5.4x and a debt-to-equity ratio of 0.7x. Revenue is forecast to grow in the first quarter, decline in the second, and increase again in the third, while EPS is expected to grow consistently over the next three quarters, with next-quarter growth projected at 7%. The average analyst target price is approximately $106.47, implying about 7% upside potential.